National Reference Laboratory of Immunology, National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria.
Department of Clinical Laboratory and Clinical Immunology, Medical University, Sofia, Bulgaria.
AIDS Res Hum Retroviruses. 2020 Jul;36(7):597-600. doi: 10.1089/AID.2020.0010. Epub 2020 Apr 15.
Iron is a key factor at various stages of HIV life cycle and determines the progression of HIV infection. Data about cellular labile iron pool (LIP) in the settings of contemporary antiretroviral therapy (cART) are lacking. Yet LIP is directly related to the generation of reactive oxygen species, and may contribute to immune activation, dysfunction, and exhaustion. Using multiparameter flow cytometry, we evaluated LIP in CD4 and CD8 T cells from HIV+ patients with sustained viral suppression (SVS) as a result of continuous long-term cART. Based on the recovery of CD4/CD8 ratio, two patients' subgroups were defined: A ( = 26), CD4/CD8 > 0.9, and B ( = 37), CD4/CD8 < 0.9, with significantly differing CD4 absolute count (AC) (mean 752 vs. 571 cells/μL, < .05). Although hemoglobin and serum iron had recovered in all patients, CD4 T cell LIP and CD8 T cell LIP were significantly higher than that of controls, both in the subgroup with complete (A) and with incomplete (B) immune recovery [mean CD4 mean fluorescence intensity (ΔMFI) 318.7 and 777.8 vs. 157.6; mean CD8 ΔMFI 359.5 and 628.7 vs. 179.2, analysis of variance < .05 for both]. CD4 LIP correlated inversely with CD4 AC ( = -0.4, < .01), and both CD4 LIP and CD8 LIP-with CD4/CD8 ratio ( = -0.4, < .01). Thus, increased CD4 T cell LIP and CD8 T cell LIP in the settings of SVS and immune recovery are a sensitive marker of residual immune activation and may predict immune exhaustion in long-term cART-treated patients.
铁是 HIV 生命周期各个阶段的关键因素,并决定 HIV 感染的进展。关于当代抗逆转录病毒治疗 (cART) 背景下细胞不稳定铁池 (LIP) 的数据尚不清楚。然而,LIP 与活性氧的产生直接相关,可能导致免疫激活、功能障碍和衰竭。我们使用多参数流式细胞术评估了 HIV 阳性患者持续病毒抑制 (SVS) 时 CD4 和 CD8 T 细胞中的 LIP,这些患者由于长期 cART 而持续抑制病毒。根据 CD4/CD8 比值的恢复情况,定义了两个患者亚组:A( = 26),CD4/CD8 > 0.9,和 B( = 37),CD4/CD8 < 0.9,CD4 绝对计数(AC)差异显著(均值 752 与 571 个/μL, < .05)。尽管所有患者的血红蛋白和血清铁均已恢复,但 CD4 T 细胞 LIP 和 CD8 T 细胞 LIP 明显高于对照组,完全免疫恢复(A)和不完全免疫恢复(B)亚组均如此 [CD4 平均荧光强度(ΔMFI)均值分别为 318.7 和 777.8 与 157.6;CD8 ΔMFI 均值分别为 359.5 和 628.7 与 179.2,方差分析 < .05]。CD4 LIP 与 CD4 AC 呈负相关( = -0.4, < .01),CD4 LIP 和 CD8 LIP 与 CD4/CD8 比值呈负相关( = -0.4, < .01)。因此,SVS 和免疫恢复背景下 CD4 T 细胞 LIP 和 CD8 T 细胞 LIP 的增加是残留免疫激活的敏感标志物,并可能预测长期 cART 治疗患者的免疫衰竭。